Increasing cases of cancer and cardiovascular diseases, growing investment in research and development for novel drug, and rising awareness are expected to improve sales prospects
Increasing cases of cancer and cardiovascular diseases, growing investment in research and development for novel drug, and rising awareness are expected to improve sales prospects
Award winning market research firm Fact.MR’s report predicts anti-inflammatory cytokines market to post impressive growth through 2021 and beyond, underpinned by the rising prevalence of cancer, infectious diseases and cardiovascular disease across the globe.
The market is anticipated to witness an growth at a positive rate through 2031, with surging cases of rare skin disorders and cancer across the U.S. and U.K. Increasing research & development (R&D) activities for the drug development that reduces the infection and inflammation caused due to chemotherapy is aiding the growth.
Also, fast-track drug approval and commercialization of biopharmaceutical drugs is expected to lead the expansion of anti-inflammatory cytokines market over the coming years. Furthermore, burgeoning various cancer cases across the globe such as skin cancer have furthered the adoption of anti-inflammatory cytokines drugs.
According to the recent report of World Health Organization (WHO), around 19.2 million cases of cancer were recorded across the globe. Hence, there has been a major uprising in the healthcare expenditure since past couple of years. Developed as well as developing nations are continuously investing to improve their healthcare infrastructure and contribution form GDP leading to advancements in the healthcare facilities.
Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5661
Also, manufacturers are continuously conducting R&D activities for the development of oral and intravenous drugs that reduces the side effects caused by cytokines drugs. Moreover, favorable government reimbursement policies and initiatives for the awareness of anti-inflammatory cytokines drugs are expected to increase the treatment adoption rate. Thereby, accelerating the market growth.
“Increasing awareness regarding the anti-inflammatory therapeutics have been encouraging manufacturers to increase the production of cytokines drugs. This will also assist them to gain fast-track drug approval, thereby increasing their revenue share,” says the Fact.MR analyst.
Key Takeaways from Fact.MR’s Anti-inflammatory cytokines Study
- Rising prevalence of skin cancer across the U.S. is expected to spur the sales of anti-inflammatory cytokines
- China is anticipated to be the key contributor for the market growth, as being the largest exporter of raw materials used in anti-inflammatory cytokines.
- High investments towards the research & development activities across U.K. is expected to widen the growth opportunities for market players
- In terms of indication, cancer segment is anticipated to be dominant throughout the forecast period
- Oral route of administration is expected to be the most preferred as compared to others
- Rising prevalence of cardiovascular disease is expected to bolster the production of anti-inflammatory cytokines, spurring the sales
Prominent Drivers
- Rising incidence of cancer is expected to bolster the demand of anti-inflammatory cytokines
- Increased research & development activities for development of cytokines therapy with reduced side-effects will propel the market growth
- Rising number of improved healthcare facilities across developed nations is improving the growth
Key Restraints
- Stringent regulatory provisions regarding drug approvals is limiting market growth
- Unavailability of established and advanced healthcare in emerging economies and less developed region is restricting the growth of anti-inflammatory cytokines
- Adverse effects caused due to the intake of cytokines drugs is expected to restrain the demand
Discover more about the anti-inflammatory cytokines market with figures and data tables, along with the table of contents.
https://www.factmr.com/report/anti-inflammatory-cytokines-market
Competitive Landscape
Prominent manufacturers are conducting research & development activities for the expansion of their product portfolio by manufacturing cytokines drugs necessitating the demand from end-users.
On 25th March 2021, Medicenna Therapeutics Corp., a clinical stage immuno-oncology company announced an oral presentation of preclinical data on MDNA11 with Anti-PD-1 Therapy and unveils novel bifunctional superkines at the cytokine based cancer immunotherapies summit.
In December 2020, Bioniz Therapeutics Inc. announced the clinical data of BNZ-1, first anti-cytokine therapy to demonstrate efficacy in treating refractory cutaneous T-cell lymphoma.
In June 2020, CytoSorbents Corporation, a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients across the globe announced the commercial launch and immediate availability of CytoSorb in Latin American countries such as Colombia, Argentina, Perú, Guatemala, Ecuador, Bolivia, the Dominican Republic, El Salvador, and Costa Rica.
Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5661
Some of the prominent market players operating in anti-inflammatory cytokines market are:
- Merck KGaA
- Eli Lilly and Company
- Pfizer Inc.
- Sanofi S.A.
- Novartis AG
- Hoffmann-La Roche Ltd.
- Lonza Group Ltd.
- Thermo Fisher Scientific
- Meridian Bioscience Inc.
- General Electric Company
- Abcam PLC
- GenScript Biotech Corp
- Applied Biological Materials Inc.
- Randox Laboratories
- Others
More Insights on the Anti-inflammatory cytokines Market
Fact.MR, in its new offering, brings to fore an unbiased analysis of the global anti-inflammatory cytokines market. The study divulges compelling insights on the market based on:
Drugs
- Interleukin-1 receptor antagonist
- Interleukin-4
- Interleukin-6
- Interleukin-10
- Interleukin-11
- Interleukin-13
Route of Administration
- Oral
- Intravenous
- Others
Indication
- Graft-vs-host disease
- Cystic Fibrosis
- Cardiovascular diseases
- Adipose tissue metabolism and obesity
- Osteoarthritis
- Atherosclerosis
- Cancer
- Infectious diseases
- Others
Distribution Channel
- Institutional Sales
- Hospitals
- Speciality Clinics
- Research Institutes
- Retail Sales
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Explore Fact.MR’s Coverage on the Healthcare Domain
Inflammatory Skin Disease Treatment Market: A recent report by Fact.MR provides an in-depth analysis about the global inflammatory skin disease treatment market for the forthcoming decade. The report’s primary objective is to provide information and updates pertaining to growth opportunities in the global market for inflammatory skin disease treatment.
Peptides Heparin Market: The scope of this Fact.MR’s report is to analyze the global peptides heparin market for the upcoming forecast period, and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global peptides heparin market can benefit from the analysis offered in this report.
Inflammation Supplements Market: A recent study by Fact.MR on the inflammation supplements market offers a forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of inflammation supplements.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Source: Fact.MR